<?xml version="1.0" encoding="UTF-8" ?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-10-01T04:11:59Z</responseDate><request verb="GetRecord" metadataPrefix="oai_dc" identifier="oai:10442/0446">https://phdtheses.ekt.gr/eadd_oai/request</request><GetRecord><record><header><identifier>oai:10442/0446</identifier><datestamp>2024-06-16T21:29:36Z</datestamp><setSpec>hdl_10442_2</setSpec></header><metadata><oai_dc:dc xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd"><dc:description xmlns:lang="en">IN THE PRESENT MEDICAL WORK THE RESPECTIVE STUDIES TOOK PLACE. FIRST,  THE FREQUENT VEIN THROMBOSIS AFTER THE OPERATION IN PATIENTS WHO  WERE OPERATED FOR OVER PUBERTY PROSTATE AND FOR THE COMPETENCE OF  SOULFIPYRAZONE TO PREVENT SUCH SICKNESS. THE SULTINS GRAZONE WAS  PROVIDED BY DOUBLE BLIND TEST AND THE DIAGNOSIS OF THE VEIN THROMBOSIS  WAS DONE CLINICALLY BY THE RADIOACTIVE SYSTEM INDICATED BY I 125. A STUDY  WAS DONE TOTALLY TO 84 PATIENTS WHO WERE DIVIDED IN TWO TEAMS. THE  RESULTS WERE: 1) IN THE TEAM A (WITNESSES) VEIN THROMBOSIS WAS  PRESENTED IN 4 PATIENTS, THAT IS 9,5%, WHILE BY THE METHAL OF RADIOACTIVITY  TO 14 PATIENTS THAT IS 33,3%, 2) IN THE TEAM B THE CLINIC VEIN THROMBOSIS WAS  DIAGNOSED IN 2 PATIENTS THAT IS 4,8% WHILE BY THE METHOD OR RADIOACTIVITY  TO PATIENTS THAT IS 16,7%, 3) THE STATISTICAL ANALYSIS OF THE FREQUENT VEIN  THROMBOSIS BETWEEN THE TWO TEAMS SHOWED THAN B WAS LESS EFFECTED  THAN THE TEAM A (WITNESS)SOMEHOW REMARKABLE = P &lt; 0,02.</dc:description><dc:description xmlns:lang="el">ΕΜΕΛΕΤΗΘΗΣΑΝ 84 ΑΣΘΕΝΕΙΣ ΟΙ ΟΠΟΙΟΙ ΥΠΟΒΛΗΘΗΣΑΝ ΣΕ ΥΠΕΡΗΒΙΚΗ  ΠΡΟΣΤΑΤΕΚΤΟΜΗ ΚΑΙ ΕΧΟΡΗΓΗΘΗ ΕΙΣ ΤΟΥΣ 42 1G SULTIN PYRAZONE ΚΑΙ ΕΙΣ ΤΟΥΣ  ΑΛΛΟΥΣ 42 ΑΔΡΑΝΗΣ ΟΥΣΙΑ PLACEB. Η ΕΡΓΑΣΙΑ ΕΓΕΝΕΤΟ ΔΙΑ ΔΙΠΛΗΣ ΤΥΦΛΗΣ  ΔΟΚΙΜΑΣΙΑΣ. ΔΙΑΠΙΣΤΩΘΗΚΑΝ ΤΑ ΕΞΗΣ:1) ΕΙΣ ΤΗΝ ΟΜΑΔΑ Α (ΜΑΡΤΥΡΕΣ  ΦΛΕΒΟΘΡΟΜΒΩΣΙΣ ΠΑΡΕΤΗΡΗΘΗ ΚΛΙΝΙΚΩΣ ΕΙΣ 4 ΑΤΟΜΑ, ΠΟΣΟΣΤΟ 9,5% ΕΝΩ ΔΙΑ  ΤΗΣ ΡΑΔΙΟΙΣΟΤΟΠΙΚΗΣ ΜΕΘΟΔΟΥ ΕΙΣ 14 (ΠΟΣΟΣΤΟ 33,3%). 2) ΕΚΤΩΝ ΑΣΘΕΝΩΝ ΤΗΣ  ΟΜΑΔΟΣ Β ΚΛΙΝΙΚΗ ΦΛΕΒΟΘΡΟΜΒΩΣΙΣ ΔΙΑΓΝΩΣΘΗ ΕΙΣ 2 ΑΤΟΜΑ, ΗΤΟΙ ΠΟΣΟΣΤΟ 4,8%  ΕΝΩ ΔΙΑ ΤΗΣ ΡΑΔΙΟΙΣΟΤΟΠΙΚΗΣ ΜΕΘΟΔΟΥ ΕΙΣ 7 ΑΤΟΜΑ ΗΤΟΙ ΠΟΣΟΣΤΟ 16,7%. 3) Η  ΣΤΑΤΙΣΤΙΚΗ ΑΝΑΛΥΣΙΣ ΤΗΣ ΣΥΧΝΟΤΗΤΟΣ ΤΗΣ ΦΛΕΒΟΘΡΟΜΒΩΣΕΩΣ ΜΕΤΑΞΥ ΤΩΝ 2  ΟΜΑΔΩΝ ΕΔΕΙΞΑΝ ΟΤΙ Η ΟΜΑΣ Β ΕΝΕΦΑΝΙΣΑΝ ΜΙΚΡΟΤΕΡΑ ΣΥΧΝΟΤΗΤΑ ΤΩΝ  ΜΑΡΤΥΡΩΝ, ΣΤΑΤΙΣΤΙΚΩΣ ΣΗΜΑΝΤΙΚΗ (Ρ &lt; 0,02).</dc:description><dc:title xmlns:lang="el">ΦΛΕΒΟΘΡΟΜΒΩΣΙΣ ΚΑΙ ΠΡΟΛΗΨΙΣ ΑΥΤΗΣ ΔΙΑ ΣΟΥΛΦΙΝΠΥΡΑΖΟΝΗΣ ΕΠΙ ΥΠΕΡΗΒΙΚΗΣ ΠΡΟΣΤΑΤΕΚΤΟΜΗΣ</dc:title><dc:title xmlns:lang="en">VEIN THROMBOSIS AND THROMBUS PREVENTION BY SOULFINPYRAZONE ON OVERPUBERTY PROSTATE</dc:title><dc:creator xmlns:lang="en">Trovas, Alexandros</dc:creator><dc:creator xmlns:lang="el">Τροβάς,  Αλέξανδρος</dc:creator><dc:date>1986</dc:date><dc:language>gre</dc:language><dc:subject xmlns:lang="el">Προστατεκτομή</dc:subject><dc:subject xmlns:lang="el">ΣΟΥΛΦΙΝΠΥΡΑΖΟΝΗ</dc:subject><dc:subject xmlns:lang="el">ΦΛΕΒΟΘΡΟΜΒΩΣΙΣ</dc:subject><dc:subject xmlns:lang="en">PROSTATECTOME</dc:subject><dc:subject xmlns:lang="en">SULFINPYRAZONE</dc:subject><dc:subject xmlns:lang="en">Vein thrombosis</dc:subject><dc:publisher xmlns:lang="en">National and Kapodistrian University of Athens</dc:publisher><dc:publisher xmlns:lang="el">Εθνικό και Καποδιστριακό Πανεπιστήμιο Αθηνών (ΕΚΠΑ)</dc:publisher><dc:subject xmlns:lang="el">Ιατρική και Επιστήμες Υγείας</dc:subject><dc:subject xmlns:lang="el">Κλινική Ιατρική</dc:subject><dc:subject xmlns:lang="en">Medical and Health Sciences</dc:subject><dc:subject xmlns:lang="en">Clinical Medicine</dc:subject><dc:fathernamelatin>K.</dc:fathernamelatin><dc:identifier>10.12681/eadd/0446</dc:identifier><dc:identifier>http://hdl.handle.net/10442/hedi/0446</dc:identifier><dc:type>PhD Thesis</dc:type></oai_dc:dc></metadata></record></GetRecord></OAI-PMH>